BerGenBio ASA (OSL:BGBIO) Issuance of Stock : kr253.19 Mil (TTM As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is BerGenBio ASA Issuance of Stock?

BerGenBio ASA's Issuance of Stock for the three months ended in Mar. 2024 was kr0.00 Mil.

BerGenBio ASA's Issuance of Stock for the trailing twelve months (TTM) ended in Mar. 2024 was kr253.19 Mil.

BerGenBio ASA Issuance of Stock Historical Data

The historical data trend for BerGenBio ASA's Issuance of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BerGenBio ASA Issuance of Stock Chart

BerGenBio ASA Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Issuance of Stock

Get a 7-Day Free Trial

82.79

740.85

16.63

3.22

262.05

BerGenBio ASA Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Issuance of Stock	Get a 7-Day Free Trial															-	253.19	-	-	-

BerGenBio ASA Issuance of Stock Calculation

A company may raise cash from issuing new shares. Issuance of Stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Issuance of Stock for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr253.19 Mil.

BerGenBio ASA Issuance of Stock Related Terms

Thank you for viewing the detailed overview of BerGenBio ASA's Issuance of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

BerGenBio ASA (OSL:BGBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BerGenBio ASA (OSL:BGBIO) » Definitions » Issuance of Stock

Comparable Companies

Traded in Other Exchanges

0RU5:UK 7BG0:Germany

Address

Mollendalsbakken 9, Bergen, NOR, 5009

Website

https://www.bergenbio.com

BerGenBio ASA is a clinical stage oncology biotech company, which is engaged in developing therapeutics against novel drug targets that drive aggressive cancers. Its drug candidate bemcentinib (BGB324) is d is curently being developed in STK11 mutated NSCLC and severe respiratory infections including COVID-19. .

BerGenBio ASA (OSL:BGBIO) Headlines

No Headlines